Dr Reddy's to buy UCB's select brands for Rs 800 crore

Last Updated: Wednesday, April 1, 2015, 14:43

"The acquired business is being sold on a slump sale basis. The revenues of the acquired business is approximately Rs 150 crore for the calendar year 2014," it added.

Dr Reddy's shares up on Hepatitis C drug launch plan

Last Updated: Tuesday, March 24, 2015, 19:08

Shares of Dr Reddy's Laboratories on Tuesday settled with gains of nearly 2 percent after the firm said it is planning to launch Hepatitis C drug in the country, following which its market capitalisation rose Rs 1,000 crore.

Dr Reddy's to launch Hepatitis C drug in India

Last Updated: Monday, March 23, 2015, 17:50

Dr Reddy's Laboratories today entered into an agreement with Hetero to distribute and market generic version of US-firm Gilead Sciences' Hepatitis C drug under the brand 'Resof' in India.

CAG blames I-T Dept for Rs 1348 cr tax loss in pharma sector

Last Updated: Friday, March 20, 2015, 19:28

Coming down heavily on the I-T Department, CAG has said non-compliance of procedures for giving incentives to pharmaceutical firms, including Ranbaxy, Dr Reddy's and Piramal, resulted Rs 1,348.44 crore loss to the exchequer.

Attorney Generals of Texas, California probe DRL's drug pricing mechanism

Last Updated: Wednesday, February 25, 2015, 10:50

Attorney Generals of Texas and California have separately sought information on pricing of some drugs sold by Dr Reddy's Laboratories in the US, according to the latest filing for the drug maker with SEC.

Dr Reddy's Q3 Net declines 7.09% to Rs 574.53 crore

Last Updated: Thursday, January 29, 2015, 14:04

The company had posted a consolidated net profit of Rs 618.42 crore in the October-December period of the previous financial year, it said in a BSE filing.

HC stays suspension order of Maha FDA on Dr Reddy's C&F agent

Last Updated: Friday, January 9, 2015, 14:18

Dr Reddy's Laboratories on Friday said the Bombay High Court has granted an interim stay on an order issued by the Maharashtra drug controller (FDA) for a one-month suspension of wholesale licence of the company's clearing and forwarding agent in Bhiwandi near Thane.

Dr Reddy's acquires Habitrol brand

Last Updated: Friday, December 19, 2014, 16:02

City-based drugmaker Dr Reddy's Laboratories has acquired Habitrol brand, a nicotine replacement therapy transdermal patch, from Novartis Consumer Health Inc.

Dr Reddy's launches generic anti-viral tablets in US market

Last Updated: Tuesday, December 16, 2014, 13:42

The tablets are generic version of Roche's Valcyte tablets, it added.

Dr Reddy's launches generic anti-viral tablets in US market

Last Updated: Tuesday, December 16, 2014, 13:42

The tablets are generic version of Roche's Valcyte tablets, it added.

24 SEZ developers seek more time for projects; 3 to surrender

Last Updated: Thursday, January 16, 2014, 16:31

As many as 24 special economic zone (SEZ) developers including Dr Reddy's Lab and Tata Consultancy Services have sought more time from the government to execute their projects.

Indian cos in FDA's first list for generic Aciphex tablets

Last Updated: Sunday, November 10, 2013, 13:14

In a decision that will cheer the domestic pharma industry, Indian firms including Dr Reddy's, Lupin and Torrent Pharma have received nod from the US health regulator to market the first generic version of Aciphex, used to treat gastroesophageal reflux disease (GERD).